199 related articles for article (PubMed ID: 32540096)
1. [Relevance of antibodies in hematopoietic stem cell transplantation: Antibodies anti-HLA, anti-platelets, anti-granulocytes, anti-erythrocytes and anti-MICA. Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)].
Delbos F; Blouin L; Bruno B; Crocchiolo R; Desoutter J; Detrait M; Nguyen-Lejarre KT; Giannoli C; Lemarié C; Renac V; Yakoub-Agha I; Dubois V
Bull Cancer; 2020 Dec; 107(12S):S159-S169. PubMed ID: 32540096
[TBL] [Abstract][Full Text] [Related]
2. [Haploidentical hematopoietic stem cell transplantation: Guidelines from the Francophone society of marrow transplantation and cellular therapy (SFGM-TC)].
Nguyen S; Chalandon Y; Lemarie C; Simon S; Masson D; Dhedin N; Suarez F; Renaud B; Charbonnier A; Yafour N; François S; Duléry R; Blaise D; Yakoub-Agha I; Rubio MT
Bull Cancer; 2016 Nov; 103(11S):S229-S242. PubMed ID: 27842860
[TBL] [Abstract][Full Text] [Related]
3. [Haploidentical hematopoietic stem cell transplant: How to choose the best donor? Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)].
Dubois V; Amokrane K; Beguin Y; Bruno B; Chevallier P; Delbos F; Devillier R; Giannoli C; Guidicelli G; Harif M; Loiseau P; Rouzaire PO; Varlet P; Yakoub-Agha I; Nguyen S
Bull Cancer; 2020 Jan; 107(1S):S72-S84. PubMed ID: 31586527
[TBL] [Abstract][Full Text] [Related]
4. Combination treatment of rituximab and donor platelets infusion to reduce donor-specific anti-HLA antibodies for stem cells engraftment in haploidentical transplantation.
Zhang R; He Y; Yang D; Jiang E; Ma Q; Pang A; Zhai W; Wei J; Feng S; Han M
J Clin Lab Anal; 2020 Jul; 34(7):e23261. PubMed ID: 32112480
[TBL] [Abstract][Full Text] [Related]
5. Methodological and clinical aspects of alloimmunization after granulocyte transfusion in patients undergoing allogeneic stem cell transplantation.
Flaxa J; Rosner A; Hölig K; Bornhäuser M; Wassmuth R
Tissue Antigens; 2015 Feb; 85(2):93-103. PubMed ID: 25515298
[TBL] [Abstract][Full Text] [Related]
6. [Platelet allo-antibodies identification strategies for preventing and managing platelet refractoriness].
Basire A; Picard C
Transfus Clin Biol; 2014 Nov; 21(4-5):193-206. PubMed ID: 25277423
[TBL] [Abstract][Full Text] [Related]
7. The Role of HLA Antibodies in HLA Mismatched Allogeneic Hematopoietic Stem Cell Transplantation.
Zhang X; Wang J; Zhou Z; Zhang Y; Liu H; Tong C; Yu C; Lu Y; Zhao Y; Xiong M; Zhou JR; Juan S; Liu DY; Wei Z; Zhang J; Wu T; Lu DP
Clin Transpl; 2014; ():245-50. PubMed ID: 26281152
[TBL] [Abstract][Full Text] [Related]
8. [Impact of anti-HLA antibodies on outcomes of allogeneic stem cell transplantation: a report by the SFGM-TC].
Loiseau P; Dubois V; Bonafoux B; Bulabois CE; Coiteux V; Eliaou JF; Labaky M; Michallet M; Renac V; Delbos F; Kennel A; Detrait M; Devys A; Galambrun C; Yakoub-Agha I;
Pathol Biol (Paris); 2014 Aug; 62(4):226-9. PubMed ID: 24973858
[TBL] [Abstract][Full Text] [Related]
9. Clinical relevance of major histocompatibility complex class I chain-related molecule A (MICA) antibodies in live donor renal transplantation - Indian Experience.
Baranwal AK; Bhat DK; Goswami S; Agarwal SK; Kaur G; Mehra N
Scand J Immunol; 2020 Nov; 92(5):e12923. PubMed ID: 32593197
[TBL] [Abstract][Full Text] [Related]
10. Diagnosis and treatment of immunological platelet refractoriness by histocompatibility.
Fagundes IS; Franz JM; Jobim MS; Arend A; Merzoni J; Cardone JM; Gil B; Sekine L; Jobim LF
Hum Immunol; 2020 May; 81(5):197-201. PubMed ID: 32067841
[TBL] [Abstract][Full Text] [Related]
11. Donor-specific antibodies against HLA, MICA, and GSTT1 in patients with allograft rejection and C4d deposition in renal biopsies.
Alvarez-Márquez A; Aguilera I; Gentil MA; Caro JL; Bernal G; Fernández Alonso J; Acevedo MJ; Cabello V; Wichmann I; Gonzalez-Escribano MF; Núñez-Roldán A
Transplantation; 2009 Jan; 87(1):94-9. PubMed ID: 19136897
[TBL] [Abstract][Full Text] [Related]
12. Complement-fixing antibodies against denatured HLA and MICA antigens are associated with antibody mediated rejection.
Cai J; Terasaki PI; Zhu D; Lachmann N; Schönemann C; Everly MJ; Qing X
Exp Mol Pathol; 2016 Feb; 100(1):45-50. PubMed ID: 26615783
[TBL] [Abstract][Full Text] [Related]
13. Complement-Binding Donor-Specific Anti-HLA Antibodies and Risk of Primary Graft Failure in Hematopoietic Stem Cell Transplantation.
Ciurea SO; Thall PF; Milton DR; Barnes TH; Kongtim P; Carmazzi Y; López AA; Yap DY; Popat U; Rondon G; Lichtiger B; Aung F; Afshar-Kharghan V; Ma Q; Fernández-Viña M; Champlin RE; Cao K
Biol Blood Marrow Transplant; 2015 Aug; 21(8):1392-8. PubMed ID: 25985919
[TBL] [Abstract][Full Text] [Related]
14. [Transfusion in autologous and allogenic hematopoietic stem cell transplant: Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)].
Giraud C; Thibert JB; Desbrosses Y; Debiol B; Alsuliman T; Bardiaux L; Garban F; Huynh TNP; Samsonova O; Yakoub-Agha I; Bruno B
Bull Cancer; 2019 Jan; 106(1S):S52-S58. PubMed ID: 30665669
[TBL] [Abstract][Full Text] [Related]
15. Heart transplantation across antibodies against human leukocyte antigen and ABO-post-transplant follow-up of donor reactive antibodies.
Bućin D; Johansson S; Lindberg LO
Xenotransplantation; 2006 Mar; 13(2):101-4. PubMed ID: 16623800
[TBL] [Abstract][Full Text] [Related]
16. Ageing on the impact of distribution about preformed anti-HLA and anti-MICA antibody specificities in recipients prior to initial HSCT from East China.
Pan Q; Ma X; You Y; Yu Y; Fan S; Wang X; Wang M; Gao M; Gong G; Miao K; Shen J; Zhou X
Immun Ageing; 2024 Feb; 21(1):15. PubMed ID: 38378602
[TBL] [Abstract][Full Text] [Related]
17. Major ABO-incompatible hematopoietic stem cell transplantation: study of post-transplant pure red cell aplasia and endothelial cell chimerism.
Mueller RJ; Stussi G; Odermatt B; Halter J; Schanz U; Seebach JD
Xenotransplantation; 2006 Mar; 13(2):126-32. PubMed ID: 16623806
[TBL] [Abstract][Full Text] [Related]
18. [Second allogeneic (update). Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)].
Yafour N; Couturier MA; Borel C; Charbonnier A; Coman T; Fayard A; Masouridi-Levrat S; Yakoub-Agha I; Roy J
Bull Cancer; 2024 Feb; 111(2S):S29-S39. PubMed ID: 37045732
[TBL] [Abstract][Full Text] [Related]
19. Posttransfusion purpura following bone marrow transplantation.
Evenson DA; Stroncek DF; Pulkrabek S; Perry EH; Radford J; Miller JS; Verfaillie C
Transfusion; 1995 Aug; 35(8):688-93. PubMed ID: 7631411
[TBL] [Abstract][Full Text] [Related]
20. Post transplant development of MICA and anti-HLA antibodies is associated with acute rejection episodes and renal allograft loss.
Panigrahi A; Gupta N; Siddiqui JA; Margoob A; Bhowmik D; Guleria S; Mehra NK
Hum Immunol; 2007 May; 68(5):362-7. PubMed ID: 17462503
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
